Article Categories
Allergy and Immunology
Cardiology
Clinical Procedures
Critical Care
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology
Genomic Medicine
Hematology
Infectious Diseases
Nephrology
Neurology
Obstetrics and Gynecology
Oncology
Pathology
Perioperative Care
Physical & Rehabilitation
Psychiatry
Pulmonology
Radiology
Rheumatology
Sports Medicine
Browse Categories
Browse Drugs
Browse Journals
Search
Browse Categories
Browse Categories
Allergy and Immunology
Cardiology
Clinical Procedures
Critical Care
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology
Genomic Medicine
Hematology
Infectious Diseases
Nephrology
Neurology
Obstetrics and Gynecology
Oncology
Pathology
Perioperative Care
Physical & Rehabilitation
Psychiatry
Pulmonology
Radiology
Rheumatology
Sports Medicine
Browse Journals
Publications by authors named "Emily Y Weng"
Page
1
of
1
A phase 2 multiple ascending dose study of the inhaled pan-JAK inhibitor nezulcitinib (TD-0903) in severe COVID-19.
Dave Singh
Maxim Bogus
Valentyn Moskalenko
Robert Lord
Edmund J Moran
Emily Y Weng
Eur Respir J
October 2021
https://bit.ly/35Xs1Rf
View Article and Find Full Text PDF
Privacy Policy
Site Map
Contact Us
© LitMetric 2024. All rights reserved.
